AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3190970
Drug: Midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.5 mg kg‐1
Trial: 15276659
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER 37.5 mg
Trial: 15276659
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER 150 mg
Trial: 10720128
Drug: Cranial Radiation
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranial Radiation Therapy (CRT)
Trial: 10720128
Drug: No Cranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Cranial Radiation Therapy (CRT-)
Trial: 8965154
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion (2 liters of a nutritive amino acid solution containing approximately 2.25 g/liter lysine‐glutamate and 2.50 g/liter arginine)
Trial: 31280997
Drug: Intravenous N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous N-acetylcysteine (200 mg/kg per hour for the first 8 hours, followed by 100 mg/kg per hour for another 16 hours, same dose for another 24 hours)
Trial: 26466684
Drug: First-line antidepressant
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line antidepressant minimum dosing strategy
Trial: 26466684
Drug: First-line antidepressant
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line antidepressant maximum dosing strategy
Trial: 26466684
Drug: Second-line antidepressant
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line antidepressant continuation strategy
Trial: 26466684
Drug: Second-line antidepressant
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line antidepressant augmentation strategy
Trial: 26466684
Drug: Second-line antidepressant
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line antidepressant switching strategy
Trial: 21411151
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL chlorhexidine (CHX) application
Trial: 17700131
Drug: Contour I
RxNorm normalized name: STOMA CAP,CONTOUR I 50MM H#1796
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contour I device treatment (one treatment in abdomen, thighs, or flanks)
Trial: 15499438
Drug: WHO-17D and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHO-17D and Brazilian 17DD yellow fever vaccines
Trial: 8237624
Drug: Captopril 12.5
RxNorm normalized name: captopril 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 12.5 mg twice daily
Trial: 3586503
Drug: Intravenous deferoxamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous deferoxamine (2 g)
Trial: 3586503
Drug: Intravenous deferoxamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous deferoxamine (1 g)
Trial: 3586503
Drug: Intramuscular deferoxamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular deferoxamine (1 g)
Trial: 3586503
Drug: Intraperitoneal deferoxamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal deferoxamine (2 g)
Trial: 3586503
Drug: Intravenous and
RxNorm normalized name: immune globulin intravenous and subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and intraperitoneal deferoxamine
Trial: 28034064
Drug: Three-Dimensional Conformal
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-Dimensional Conformal External Beam Radiation Therapy (3D-CRT)
Trial: 26579041
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBTp)
Trial: 19549094
Drug: Rosuvastatin (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (10-40 mg OD)
Trial: 19549094
Drug: Atorvastatin (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (20-80 mg OD)
Trial: 19549094
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg OD)
Trial: 19549094
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg OD)
Trial: 10735790
Drug: Remifentanil (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (0.25 microg. kg(‐1). min(‐1) continuous infusion)
Trial: 10735790
Drug: Fentanyl (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (2 microg/kg bolus followed by placebo continuous infusion)
Trial: 8737620
Drug: Intranasal carbocalcitonin
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal carbocalcitonin (80 U MRC daily for 12 months)
Trial: 1591369
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cisplatin, decarbazine, carmustine, and tamoxifen
Trial: 1591369
Drug: Biological response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Biological response modifiers (interleukin‐2 and alpha‐interferon)
Trial: 29424335
Drug: Test preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test preparation (entecavir tablet)
Trial: 29424335
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation (entecavir tablet)
Trial: 19901102
Drug: Pregabalin 75
RxNorm normalized name: pregabalin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 75 mg twice daily
Trial: 20118030
Drug: Prophylactic pegfilgrastim
RxNorm normalized name: Pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Prophylactic pegfilgrastim use (all cycles of chemotherapy)
Trial: 7021266
Drug: Fentiazac 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentiazac 5% cream
Trial: 31260794
Drug: Weight-driven recommendation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-driven recommendation of restricted fluid intake, diuretics, and ultrafiltration initiated from 48 hours up to 14 days after admission.
Trial: 26187183
Drug: Simplified cardiovascular
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simplified cardiovascular management program delivered by community health workers using an Android app, focusing on medication use and lifestyle modifications.
Trial: 24172699
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus alpha-lipoic acid 300 mg twice daily
Trial: 21645507
Drug: Exenatide 5
RxNorm normalized name: EXENATIDE 5MCG/DOSE 1.2ML 60D PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide 5 μg twice a day (titrated to 10 μg twice a day after 1 month)
Trial: 21645507
Drug: Glimepiride 1
RxNorm normalized name: glimepiride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride 1 mg three times a day (titrated to 2 mg three times a day after 1 month)
Trial: 19468259
Drug: Standard procedure
RxNorm normalized name: HOMOSALATE 60 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL STICK [Standard Procedure Lip Balm SPF 50]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard procedure to reach a treatment agreement (control)
Trial: 15232804
Drug: Sevoflurane 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane 2% added to cardioplegia solution
Trial: 11389784
Drug: Estrogen or
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen or hormone replacement therapy (ERT or HRT)
Trial: 9517609
Drug: Beclomethasone dipropionate,
RxNorm normalized name: Beclomethasone Dipropionate, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate, 84 microg twice a day
Trial: 3191663
Drug: Timolol (non-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (non-selective beta-blocker, 10 mg b.i.d. for 5 days)
Trial: 3191663
Drug: Metoprolol (beta-1-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (beta-1-selective beta-blocker, 100 mg b.i.d. for 5 days)
Trial: 3191663
Drug: Timolol (non-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (non-selective beta-blocker)
Trial: 3191663
Drug: Metoprolol (beta-1-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (beta-1-selective beta-blocker)
Trial: 26682793
Drug: Both beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both beta-blockers
Trial: 30283184
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (30 mg/kg loading dose over 15 min, followed by 10 mg/kg/h for 1 h)
Trial: 30283184
Drug: Paracetamol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (10 mg/kg infusion started with induction and continued for 1 h)
Trial: 25407227
Drug: Dietary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intervention consisting of olive oil for cooking, an olive oil based spread, and a daily supplement drink enriched with Vitamin D (10 microgram daily) and marine omega‐3 fatty acids (2 g daily) for 6 weeks preconception
Trial: 25407227
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet of sunflower seed oil for cooking, a sunflower oil based spread, and a daily supplement drink without added Vitamin D or marine omega‐3 fatty acids
Trial: 22957013
Drug: Erythropoietin (EPO)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (EPO) treatment at a dose of 50 IU/kg/week for 3 injections over 18 days
Trial: 8678066
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no EPO treatment)
Trial: 19440168
Drug: Discoblock (intradisc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discoblock (intradisc injection of 0.75 mL of 0.5% bupivacaine)
Trial: 19440168
Drug: Discography (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discography (1.5 mL of contrast medium)
Trial: 12701864
Drug: BSE with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BSE with postoperative MMC 0.02% drops twice a day for 5 days
Trial: 8818848
Drug: Cefaclor 250
RxNorm normalized name: cefaclor 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor 250 mg three times daily for 10 days
Trial: 1373360
Drug: Tamoxifen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (30 mg/day)
Trial: 26002873
Drug: Integrated Violence
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated Violence Prevention Treatment (IVPT)
Trial: 22868247
Drug: Intermittent LHRH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent LHRH therapy
Trial: 22868247
Drug: Continuous LHRH
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous LHRH therapy
Trial: 19684500
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) treatment for 12 sessions (5 sessions per week)
Trial: 17373863
Drug: First ONS
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First ONS (oral nutritional supplement)
Trial: 9404990
Drug: Op-Site treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Op-Site treatment
Trial: 7506159
Drug: Nimesulide 200mg
RxNorm normalized name: nimesulide 200 MG
DrugBank: Nimesulide (DB04743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 200mg twice daily
Trial: 7506159
Drug: Naproxen 500mg
RxNorm normalized name: NAPROXEN 500MG TAB
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen 500mg twice daily
Trial: 3711534
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg oral dipyridamole
Trial: 3711534
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg oral dipyridamole
Trial: 3711534
Drug: Oral dipyridamole
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dipyridamole (200 or 400 mg)
Trial: 31729600
Drug: R,S‐1,3‐butanediol (BD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R,S‐1,3‐butanediol (BD) 0.35 g kg‐1
Trial: 31258919
Drug: Vilanterol 25
RxNorm normalized name: FLUTIC 50/VILANTEROL 25MCG 30D ORAL INH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilanterol 25 µg (VI)
Trial: 31258919
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate 100 µg (FF)
Trial: 31258919
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Vilanterol 25 µg and Fluticasone furoate 100 µg (VI 25/FF 100)
Trial: 9576452
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (lansoprazole 30 mg, clarithromycin 500 mg, and amoxicillin 1 gm b.i.d.)
Trial: 9576452
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (lansoprazole t.i.d. and amoxicillin t.i.d.)
Trial: 9576452
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (lansoprazole b.i.d. and clarithromycin t.i.d.)
Trial: 9576452
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (lansoprazole b.i.d. and clarithromycin b.i.d.)
Trial: 9576452
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (lansoprazole b.i.d. and amoxicillin t.i.d.)
Trial: 9576452
Drug: Monotherapy (lansoprazole)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (lansoprazole)
Trial: 9576452
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy and dual therapy
Trial: 7887102
Drug: Patient‐controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient‐controlled intravenous morphine
Trial: 21498100
Drug: GH receptor
RxNorm normalized name: Toll-like receptor 9
DrugBank: Toll-like receptor 9 (DB15320)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH receptor blocker (pegvisomant, 5 mg/day, n=9)
Trial: 12679756
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH, 5000 IU 3 times daily)
Trial: 10858919
Drug: Sulbutiamine (Arcalion)
RxNorm normalized name: sulbutiamine
DrugBank: Sulbutiamine (DB13416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulbutiamine (Arcalion) 600 mg p.d.
Trial: 2405042
Drug: Injections every
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injections every 3 months (21 patients)
Trial: 2405042
Drug: Injections every
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injections every 6 weeks (22 patients)
Trial: 28509605
Drug: Bio Pox™
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio Pox™ (indigenous investigational vaccine)
Trial: 28509605
Drug: Varivax™ (licensed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varivax™ (licensed vaccine)
Trial: 23107810
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose triamcinolone acetate
Trial: 23107810
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose triamcinolone acetate
Trial: 16957432
Drug: Adapalene gel
RxNorm normalized name: Adapalene Gel
DrugBank: Adapalene (DB00210)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adapalene gel 0.1% in combination with benzoyl peroxide/clindamycin
Trial: 16957432
Drug: Tretinoin microsphere
RxNorm normalized name: tretinoin microsphere
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin microsphere 0.04% in combination with benzoyl peroxide/clindamycin
Trial: 16957432
Drug: Tazarotene cream
RxNorm normalized name: Tazarotene Cream
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene cream 0.05% in combination with benzoyl peroxide/clindamycin
Trial: 15532202
Drug: Melatonin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (10 mg, administered 1 hour before sleep for 28 days)
Trial: 12629445
Drug: Losartan therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan therapy
Trial: 9266391
Drug: Oral uridine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral uridine powder at 150 mg/kg per day (divided dose, three times daily)
Trial: 9266391
Drug: Uridine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uridine treatment started prior to age 14 months
Trial: 7884218
Drug: 14 days
RxNorm normalized name: ponesimod
DrugBank: Ponesimod (DB12016)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 14 days of intravenous ceftriaxone alone
Trial: 7884218
Drug: Successful treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Successful treatments
Trial: 2455152
Drug: Enalaprilat (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat (5 mg i.v.)
Trial: 29475056
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy protocol for the prevention of suicide
Trial: 27595681
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 100 mg once daily
Trial: 20961244
Drug: Weekly self-testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly self-testing at home
Trial: 20961244
Drug: Monthly high-quality
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly high-quality testing in a clinic
Trial: 18178039
Drug: Triazolam 0.25
RxNorm normalized name: triazolam 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.25 mg/70 kg
Trial: 18178039
Drug: Triazolam 0.12
RxNorm normalized name: triazolam 0.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.12 mg/70 kg
Trial: 18178039
Drug: Triazolam (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (various doses: 0.00, 0.06, 0.12, and 0.25 mg/70 kg)
Trial: 16189252
Drug: Aromatase inhibitor
RxNorm normalized name: Aromatase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatase inhibitor letrozole (Lz; 2.5 mg/d)
Trial: 8666320
Drug: no treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no treatment (control group, n = 31)
Trial: 20437076
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine (n = 15)
Trial: 20437076
Drug: Sham vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham vaccine (n = 9)
Trial: 17549475
Drug: PLD 60
RxNorm normalized name: pLDLR-Neo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLD 60 mg/m² (1st cycle), 30 mg/m² (2nd cycle), 45 mg/m² (3rd cycle)
Trial: 17549475
Drug: PLD 30
RxNorm normalized name: pLDLR-Neo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLD 30 mg/m² (1st cycle), 60 mg/m² (2nd cycle), 45 mg/m² (3rd cycle)
Trial: 17549475
Drug: PLD (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLD (all doses across cycles)
Trial: 10863615
Drug: Amodiaquine (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amodiaquine (35 mg/kg over 3 days: 1st day: 15 mg/kg; 2nd day: 10 mg/kg; 3rd day: 10 mg/kg)
Trial: 10863615
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (self-medication)
Trial: 8779379
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg (Groups B, C, D, E, F)
Trial: 10736983
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg/die)
Trial: 2699465
Drug: Amitriptyline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (75 mg/die)
Trial: 7494563
Drug: Cisplatin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (75 mg/m²) + Paclitaxel (135 mg/m² over 24 hours)